dc.contributor.author | McCarthy, NE | en_US |
dc.contributor.author | Hedin, CR | en_US |
dc.contributor.author | Sanders, TJ | en_US |
dc.contributor.author | Amon, P | en_US |
dc.contributor.author | Hoti, I | en_US |
dc.contributor.author | Ayada, I | en_US |
dc.contributor.author | Baji, V | en_US |
dc.contributor.author | Giles, EM | en_US |
dc.contributor.author | Wildemann, M | en_US |
dc.contributor.author | Bashir, Z | en_US |
dc.contributor.author | Whelan, K | en_US |
dc.contributor.author | Sanderson, I | en_US |
dc.contributor.author | Lindsay, JO | en_US |
dc.contributor.author | Stagg, AJ | en_US |
dc.date.accessioned | 2016-08-16T12:52:01Z | |
dc.date.available | 2015-05-28 | en_US |
dc.date.issued | 2015-08 | en_US |
dc.date.submitted | 2016-08-01T14:27:02.779Z | |
dc.identifier.issn | 0021-9738 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/14670 | |
dc.description.sponsorship | N.E. McCarthy was funded by Crohn’s and Colitis UK (M/13/5).
C.R. Hedin was funded by Core Charity (COR002). T.J. Sanders
was funded by The Broad Medical Research Program (IBD-
0317R). | en_US |
dc.format.extent | 3215 - 3225 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | JOURNAL OF CLINICAL INVESTIGATION | en_US |
dc.rights | Authors retain rights to present the work without prior permission in original, revised, adapted, or derivative form, provided that all such use is for personal or nonprofit. Commercial use and reproduction is restricted under this agreement | |
dc.title | Azathioprine therapy selectively ablates human V delta 2(+) T cells in Crohn's disease | en_US |
dc.type | Article | |
dc.rights.holder | 2015.JCI | |
dc.identifier.doi | 10.1172/JCI80840 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359034800029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 8 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 125 | en_US |
qmul.funder | Disrupting Vδ2T-cell function in the gut: a novel approach to therapy in early stage Crohn’s disease::Crohn’s and Colitis UK | en_US |